We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Illumina to Conduct Large-Scale Genotyping Study

Study Designed to Understand Genetic Susceptibility, Mechanisms of Disease Progression, and Cancer Therapy Management.
News

Metabolon Appoints Chief Scientific Officer

Dr. Michael Milburn has been appointed as Chief Scientific Officer.
News

Affibody and NIH to Develop Molecular In Vivo Imaging Agents

Affibody will design and develop engineered Affibody® molecules specific for a receptor protein, HER2.
News

Varian Acquires Polymer Laboratories

This acquisition is part of Varian's strategy to strengthen the Company's product portfolio.
News

Sharper X-Rays of Cell's Ribosome Could Lead to Better Antibiotics

A sharper picture of the nano-machine promises to help researchers explain how some types of antibiotics work
News

Study Findings Offer Targets For Antibiotics

Many currently used antibiotics alter a ribosome's ability to make proteins.
News

Nanion Receives Bavarian Innovation Award 2005

Nanion received the award for its chip-based patch clamp technique.
News

FDA and Industry Collaborate to Predict Liver Toxicity in Human Drug Trials

The liver toxicology biomarker study aims to discover signs of human liver toxicity.
News

MorphoSys and Wacker Demonstrate High Yield Expression of Antibody Fragments

MorphoSys obtains the right to use Wacker's secretion system for antibody-fragment production.
News

ChemDiv and ProQinase to Partner in Lead Discovery

Both Companies have established partnership in the discovery and preclinical development of kinase inhibitors.
Advertisement